Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125073062 | 12507306 | 2 | F | 2016 | 20160704 | 20160629 | 20160718 | EXP | GB-AUROBINDO-AUR-APL-2016-08104 | AUROBINDO | 42.00 | YR | F | Y | 0.00000 | 20160718 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125073062 | 12507306 | 1 | PS | Ondansetron | ONDANSETRON | 1 | Unknown | UNK | U | U | 78539 | ||||||||
125073062 | 12507306 | 2 | SS | Ondansetron | ONDANSETRON | 1 | UNK | U | U | 78539 | |||||||||
125073062 | 12507306 | 3 | SS | APREPITANT. | APREPITANT | 1 | Oral | 80 MG, ONCE A DAY (TAKEN ON DAY 2 AND 3 AFTER CHEMOTHERAPY) | U | U | 0 | 80 | MG | QD | |||||
125073062 | 12507306 | 4 | SS | APREPITANT. | APREPITANT | 1 | Oral | 80 MG, ONCE A DAY (TAKEN ON DAY 2 AND 3 AFTER CHEMOTHERAPY) | U | U | 0 | 80 | MG | QD | |||||
125073062 | 12507306 | 5 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | UNK, EVERY 3 WEEKS (CYCLICAL) | U | U | 0 | ||||||||
125073062 | 12507306 | 6 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | UNK, EVERY 3 WEEKS (CYCLICAL) | U | U | 0 | |||||||||
125073062 | 12507306 | 7 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 2 MG, ONCE DAILY, 3 DAYS | U | U | 0 | 2 | MG | TABLET | QD | ||||
125073062 | 12507306 | 8 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 2 MG, ONCE DAILY, 3 DAYS | U | U | 0 | 2 | MG | TABLET | QD | ||||
125073062 | 12507306 | 9 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | 3 CYCLES | U | U | 0 | ||||||||
125073062 | 12507306 | 10 | SS | DOCETAXEL. | DOCETAXEL | 1 | 3 CYCLES | U | U | 0 | |||||||||
125073062 | 12507306 | 11 | SS | LEVOMEPROMAZINE | LEVOMEPROMAZINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
125073062 | 12507306 | 12 | SS | LEVOMEPROMAZINE | LEVOMEPROMAZINE | 1 | UNK | U | U | 0 | |||||||||
125073062 | 12507306 | 13 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | UNK | U | U | 0 | ||||||||
125073062 | 12507306 | 14 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | UNK | U | U | 0 | |||||||||
125073062 | 12507306 | 15 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, 24 HOURS AFTER CHEMOTHERAPY | U | U | 0 | 6 | MG | ||||||
125073062 | 12507306 | 16 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, 24 HOURS AFTER CHEMOTHERAPY | U | U | 0 | 6 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125073062 | 12507306 | 1 | Product used for unknown indication |
125073062 | 12507306 | 3 | Product used for unknown indication |
125073062 | 12507306 | 5 | Product used for unknown indication |
125073062 | 12507306 | 7 | Product used for unknown indication |
125073062 | 12507306 | 9 | Product used for unknown indication |
125073062 | 12507306 | 11 | Product used for unknown indication |
125073062 | 12507306 | 13 | Product used for unknown indication |
125073062 | 12507306 | 15 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125073062 | 12507306 | HO |
125073062 | 12507306 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125073062 | 12507306 | Arthralgia | |
125073062 | 12507306 | Constipation | |
125073062 | 12507306 | Decreased appetite | |
125073062 | 12507306 | Deep vein thrombosis | |
125073062 | 12507306 | Fatigue | |
125073062 | 12507306 | Oral pain | |
125073062 | 12507306 | Pain | |
125073062 | 12507306 | Pain in extremity | |
125073062 | 12507306 | Peripheral swelling | |
125073062 | 12507306 | Vascular pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |